Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ef2e9f5ce8630d9b282043b8d060caff |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C405-0058 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5585 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C405-0016 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C405-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-559 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-557 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C405-0041 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5585 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-557 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C405-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-66 |
filingDate |
1999-01-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
1999-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef0e584e92d58455100a06c069f66a28 |
publicationDate |
1999-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-5990138-A |
titleOfInvention |
Cyclopentane (ene) heptenoic or heptanoic acids and derivatives thereof useful as therapeutic agents |
abstract |
The invention relates to 7-[5-hydroxy-2-(hydroxyhydrocarbyl or heteroatom-substituted hydroxy hydrocarbyl)-3-hydroxycyclopentyl(enyl)] heptanoic or heptenoic acids and derivatives of said acids, wherein one or more of said hydroxy groups are replaced by an ether group. The compounds of the present invention are potent ocular hypotensives, and are particularly suitable for the management of glaucoma. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004122102-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6414022-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6716876-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6303658-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010074957-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006073172-A1 |
priorityDate |
1993-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |